pentoxifylline has been researched along with ST Elevation Myocardial Infarction in 1 studies
ST Elevation Myocardial Infarction: A clinical syndrome defined by MYOCARDIAL ISCHEMIA symptoms; persistent elevation in the ST segments of the ELECTROCARDIOGRAM; and release of BIOMARKERS of myocardial NECROSIS (e.g., elevated TROPONIN levels). ST segment elevation in the ECG is often used in determining the treatment protocol (see also NON-ST ELEVATION MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline is a methylxanthine derivative with known anti-inflammatory, antioxidant, vasodilator, and rheological properties which can be a promising agent in preventing reperfusion injury." | 7.30 | Evaluating the role of intravenous pentoxifylline administration on primary percutaneous coronary intervention success rate in patients with ST-elevation myocardial infarction (PENTOS-PCI). ( Aghakouchakzadeh, M; Amoli, AI; Hosseini, SH; Jalali, A; Jenab, Y; Kakavand, H; Naderian, M; Pourhosseini, H; Saadatagah, S; Sadri, F; Salarifar, M; Talasaz, AH, 2023) |
| "Pentoxifylline is a methylxanthine derivative with known anti-inflammatory, antioxidant, vasodilator, and rheological properties which can be a promising agent in preventing reperfusion injury." | 3.30 | Evaluating the role of intravenous pentoxifylline administration on primary percutaneous coronary intervention success rate in patients with ST-elevation myocardial infarction (PENTOS-PCI). ( Aghakouchakzadeh, M; Amoli, AI; Hosseini, SH; Jalali, A; Jenab, Y; Kakavand, H; Naderian, M; Pourhosseini, H; Saadatagah, S; Sadri, F; Salarifar, M; Talasaz, AH, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakavand, H | 1 |
| Saadatagah, S | 1 |
| Naderian, M | 1 |
| Aghakouchakzadeh, M | 1 |
| Jalali, A | 1 |
| Sadri, F | 1 |
| Amoli, AI | 1 |
| Hosseini, SH | 1 |
| Jenab, Y | 1 |
| Pourhosseini, H | 1 |
| Salarifar, M | 1 |
| Talasaz, AH | 1 |
1 trial available for pentoxifylline and ST Elevation Myocardial Infarction
| Article | Year |
|---|---|
Evaluating the role of intravenous pentoxifylline administration on primary percutaneous coronary intervention success rate in patients with ST-elevation myocardial infarction (PENTOS-PCI).
Topics: Administration, Intravenous; Antioxidants; Humans; Infusions, Intravenous; Myocardial Infarction; Pe | 2023 |